Phase III Study of AK-120 in Patients with Recurrent Herpes Simplex
Latest Information Update: 07 Dec 2021
At a glance
- Drugs Famciclovir (Primary)
- Indications Herpes genitalis; Herpes labialis; Herpes simplex virus infections
- Focus Therapeutic Use
- Sponsors Maruho
- 21 Feb 2019 According to an Asahi Kasei Pharma Corp media release, the company has obtained a partial change of approval for anti-herpes virus agent Famvir Tab 250 mg for the treatment of recurrent herpes simplex in Japan.
- 08 Nov 2018 Status changed from active, no longer recruiting to completed.
- 06 Jun 2017 Status changed from recruiting to active, no longer recruiting.